Efficacy of Rituximab for Minimal Change Disease and Focal Segmental Glomerulosclerosis with Frequently Relapsing or Steroid-Dependent Nephrotic Syndrome in Adults: A Chinese Multicenter Retrospective Study

Conclusion Rituximab was proven an effective and safe treatment option for adult FR/SDNS patients with MCD or FSGS in maintaining disease remission and minimizing corticosteroid exposure.PMID:37963441 | DOI:10.1159/000535010

Source: American Journal of Nephrology - November 14, 2023 Category: Urology & Nephrology Authors: Lan Lan Yuxin Lin Binfeng Yu Yin Wang Hong Pan Huijing Wang Xiaowei Lou Xiabing Lang Qiankun Zhang Lie Jin Yi Yang Liang Xiao Jianghua Chen Fei Han Source Type: research